A review of anti-inflammatory strategies in cardiac surgery

Asimakopoulos, George; Gourlay, Terence
March 2003
Perfusion;Mar2003 Supplement, Vol. 18, p7
Academic Journal
It is generally accepted that cardiac surgery is frequently associated with the development of systemic inflammatory response. This phenomenon is very variable clinically, and can be detected by measuring plasma concentrations of certain inflammatory markers. Complement component, cytokines and adhesion molecules are examples of these markers. Systemic inflammation can be potentially damaging to major organs. Several anti-inflammatory strategies have been used in recent years, aiming to attenuate the development of systemic inflammatory response. This article summarizes recently published literature concerning the use of anti-inflammatory techniques and pharmacological agents in cardiac surgery. In particular, the anti-inflammatory effects of off-pump surgery, leukocyte filtration, corticosteroids, aprotinin, phosphodiesterase inhibitors, dpoexamine, H[SUB2] antagonists and ACE inhibitors are reviewed. The overall conclusion is that although certain strategies reduce plasma levels of inflammatory mediators, convincing evidence of significant clinical benefits is yet to come.


Related Articles

  • Reply to Cikirikcioglu et al. Nashef, Samer A.M. // European Journal of Cardio-Thoracic Surgery;Jul2013, Vol. 44 Issue 1, p185 

    A letter to the editor is presented in response to the article related to anticoagulation management in cardiac surgery.

  • Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice. Codispoti, M.; Mankad, P.S. // Perfusion;Jun2000, Vol. 15 Issue 3, p191 

    Protocols for management of heparin and protamine administration in patients undergoing open-heart surgery have been developed from experience gained mainly in adult practice. However, it has been demonstrated that there are marked differences between paediatric and adult patients in their...

  • Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. de Seigneux, Sophie; Ponte, Belen; Weiss, Lucien; Pugin, Jérôme; Romand, Jacques André; Martin, Pierre-Yves; Saudan, Patrick // BMC Nephrology;2012, Vol. 13 Issue 1, p132 

    Background: Experimentally, erythropoietin (EPO) has nephroprotective as well as immunomodulatory properties when administered after ischemic renal injury. We tested the hypothesis that different doses of recombinant human EPO administered to patients after cardiac surgery would minimize kidney...

  • APTT in Heparinized Plasma: Influence of Reagent, Acute-Phase Reaction, and Interval Between Sampling and Testing. Strekerud, Finn G.; Abildgaard, Ulrich // Clinical & Applied Thrombosis/Hemostasis;Fall1996, Vol. 2 Issue 4, p250 

    Plasma samples from 10 healthy persons and 10 patients with acute-phase reaction were heparinized in vitro to obtain 0.00-0.70 U/ml. The activated partial thromboplastin time (aPTT) was then determined, using an optical method (Automated Coagulation Laboratory) and four reagents (actin,...

  • Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes. Qi, Dake; Kuo, Kuo-Hsing; Abrahani, Ashraf; An, Ding; Qi, Yadan; Heung, Jessica; Kewalramani, Girish; Pulinilkunnil, Thomas; Ghosh, Sanjoy; Innis, Sheila M.; Rodrigues, Brian // Cardiovascular Research;Oct2006, Vol. 72 Issue 1, p124 

    Abstract: Objective: Lipoprotein lipase (LPL) metabolizes the triglyceride (TG) core of lipoproteins. We evaluated whether circulating lipids can regulate LPL by influencing the transfer of enzyme from the myocyte to the endothelial lumen. Methods: Acute intralipid (IL, 10% and 20%) infusion was...

  • Pregnancy in patients with prosthetic heart valves. Oakley, Celia // British Medical Journal (Clinical Research Edition);5/28/1983, Vol. 286 Issue 6379, p1680 

    Focuses on the effects of pregnancy on patients with prosthetic heart valves. Increase in the risk of thromboembolism; Effects in the usage of coumarin anticoagulants in pregnancy; Safeness of heparin.

  • Warfarin Anticoagulation After Congenital Heart Surgery at a Large Children's Hospital. Lowry, Adam; Moffett, Brady; Moodie, Douglas; Knudson, Jarrod // Pediatric Cardiology;Dec2012, Vol. 33 Issue 8, p1377 

    Management of warfarin in pediatric patients remains a clinical challenge. Warfarin may be administered after congenital heart surgery, and the risks of morbidity can be high. Currently, no data exist to describe the initiation of warfarin and the risk factors for morbidity in post-congenital...

  • Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature. Jain, Shreepal; Vaidyanathan, Balu // Annals of Pediatric Cardiology;Jan-Jun2010, Vol. 3 Issue 1, p31 

    Recent advances in the pediatric heart surgery, especially the Fontan procedure, has necessitated an increased use of oral anticoagulants in pediatric cardiac patients. Warfarin is the standard agent used for most pediatric indications, though there are very few randomized control studies in...

  • Bivalirudin anticoagulation during cardiac surgery: a single-center experience in 141 patients. Koster, A.; Buz, S.; Krabatsch, T.; Yeter, R.; Hetzer, R. // Perfusion;Jan2009, Vol. 24 Issue 1, p7 

    The feasibility of bivalirudin for anticoagulation during cardiac surgery has been confirmed in four multicenter clinical trials. Here, we report our single-center experience with bivalirudin anticoagulation in "on-pump" and "off-pump" cardiac surgery in a large number of patients with and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics